<code id='CD4CAA78B7'></code><style id='CD4CAA78B7'></style>
    • <acronym id='CD4CAA78B7'></acronym>
      <center id='CD4CAA78B7'><center id='CD4CAA78B7'><tfoot id='CD4CAA78B7'></tfoot></center><abbr id='CD4CAA78B7'><dir id='CD4CAA78B7'><tfoot id='CD4CAA78B7'></tfoot><noframes id='CD4CAA78B7'>

    • <optgroup id='CD4CAA78B7'><strike id='CD4CAA78B7'><sup id='CD4CAA78B7'></sup></strike><code id='CD4CAA78B7'></code></optgroup>
        1. <b id='CD4CAA78B7'><label id='CD4CAA78B7'><select id='CD4CAA78B7'><dt id='CD4CAA78B7'><span id='CD4CAA78B7'></span></dt></select></label></b><u id='CD4CAA78B7'></u>
          <i id='CD4CAA78B7'><strike id='CD4CAA78B7'><tt id='CD4CAA78B7'><pre id='CD4CAA78B7'></pre></tt></strike></i>

          entertainment

          entertainment

          author:leisure time    Page View:79179
          Senator Ron Wyden. -- health policy coverage from STAT
          Sen. Ron Wyden (D-Ore.), chairman of the Senate Finance Committee Mariam Zuhaib/AP

          WASHINGTON — A key Senate committee is proposing that Medicare pay bonuses to hospitals that take measures to prevent drug shortages. It also wants to change the way doctors are paid to administer drugs in outpatient settings.

          After a startling number of drugs, including chemotherapies, were in shortage last year, Washington stepped up its efforts to find policy solutions for the problems.

          advertisement

          Most experts say the way that Medicare pays hospitals and doctors, along with the dominance of group purchasing organizations that buy hospital drugs, together force generic drugmakers to cut prices for cheaper generics so low that there is no money left for maintaining facilities or using reliable, diversified supply chains. The result is that facilities get shut down or generic drug manufacturers exit markets, leaving too few makers of drugs to supply demand.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.
          A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

          AdobeLastweek,theWashingtonPostpublishedanop-edbyformerCDCDirectorTomFriedentitled,“It’stheworld’sle

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          It's time to retire 'poor historian' from clinicians' vocabularies

          AdobeShouldwepitythe“poorhistorians”—theindividualsorfamilymemberswhocan’tgiveaclearaccountingofthei